Correction to: Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology. [PDF]
Suzuki K +15 more
europepmc +1 more source
Potentials and practical challenges of terbium-161 labeled radiopharmaceuticals. [PDF]
Ntihabose CM +11 more
europepmc +1 more source
Development of an experimental method using Cs-131 to evaluate radiobiological effects of internalized Auger-electron emitters. [PDF]
Fredericia, Pil +4 more
core
Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy-Implications for Radiopharmaceutical Repurposing (Beyond Oncology). [PDF]
Salgueiro MJ, Zubillaga M.
europepmc +1 more source
The use of mass cytometry (CyTOF) to evaluate the cellular uptake of stable radiopharmaceutical surrogates in single cells: a proof-of-concept study. [PDF]
Gómez-Sánchez M +5 more
europepmc +1 more source
Implementation of positron emission tomography radiopharmaceuticals labeled with Gallium-68 in a hospital radiopharmacy: experience with more than 7,500 patients. [PDF]
Yamaga LYI +11 more
europepmc +1 more source
Radiolabelled FAPI Radiotracers in Oncology: A Comprehensive Review of Current Diagnostic and Emerging Therapeutic Applications. [PDF]
Czuczejko J +7 more
europepmc +1 more source
Head-to-head comparison of [<sup>177</sup>Lu]Lu-FAP-2286 and [<sup>161</sup>Tb]Tb-FAP-2286 efficacy in a PDAC mouse model. [PDF]
van der Heide CD +9 more
europepmc +1 more source

